Gene Query: BRD8

Dataset Description Geneva Score
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 44.24
Crizotinib v. DMSO in SW480 cells 28.96
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 28.96
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 28.6
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 25.89
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 25.42
Transcriptional profiling of LS1034 cells treated with tepoxalin 23.48
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 22.9
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 22.85
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 21.07
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 20.4
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 20.4
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 19.89
Genome-wide transcriptional response to random aneuploidy in human cells 19.04
Rorc disruption in human FG pancreatic cancer cells 19.01
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 18.31
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 17.78
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 17.76
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 17.69
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 17.46
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 16.61
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 16.61
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 15.48
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 15.3
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 15.29
Control of prostate tumour growth by the long non-coding RNA GHSROS 15.25
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 15.02
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 14.78
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 14.78
Silencing SPIB in attached and floating state of H1703 lung cancer cells 14.71
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 14.69
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 14.59
Genes significantly down or Up-regulated upon RNF219 knockdown 14.57
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 13.99
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 13.9
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 13.17
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 13.16
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 12.98
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 12.9
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 12.8
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 12.79
12.59
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 12.57
Expression profiling of MCF-7 cells with treatment of TCDD 12.56
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 12.56
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 12.56
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 12.54
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 12.54
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  12.38
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 11.91
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 11.8
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 11.69
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 11.47
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 11.4
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 11.39
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 11.03
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 11.0
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 10.96
Total RNA-seq in ALL-SIL upon TLX1 knockdown 10.96
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 10.94
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 10.76
Differentiation enhances Zika virus infection in neuronal brain cells 10.75
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 10.74
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 10.72
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 10.71
Regulation of protein translation during mitosis 10.69
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 10.51
U1 snRNP telescripting regulates size-function stratified human genome 10.5
Total RNA-seq in ALL-SIL upon JQ1 inhibition 10.46
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 10.28
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 10.28
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 10.15
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 9.96
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 9.9
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 9.9
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 9.84
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 9.77
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 9.77
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 9.63
Differentially expressed genes post knock down of lincDUSP26 9.62
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 9.58
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 9.5
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 9.5
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 9.42
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 9.4
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 9.4
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 9.38
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 9.38
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 9.36
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 9.32
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 9.27
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 9.26
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure by siRNA knockdown of Anillin [tpo8] 9.09
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 9.06
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 9.04
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 9.04
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 9.03
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 8.99
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 8.99
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 8.91
Gene expression in PANC1 cells treated with Rakicidin 8.83
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 8.75
Identification of global regulators of T-helper cell lineage specification 8.74
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 8.74
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  8.72
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 8.7
Global analysis of alternative splicing regulated by RBM10 8.69
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 8.58
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 8.54
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 8.54
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 8.54
RNA-Seq from human ILC transitional populations 8.41
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 8.41
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 8.4
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 8.39
Human RELA haploinsufficiency results in autosomal dominant chronic mucocutaneous ulceration: the transcriptional profile of RelA haploinsufficient patients 8.38
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 8.29
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 8.29
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 8.26
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 8.26
Transcriptome profiling of Normal and Cancerous Prostate Cells 8.25
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 8.24
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 8.24
Expression by CD133+ cells isolated from the adult human exocrine pancreas 8.2
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 8.16
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 8.1
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 8.08
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 8.06
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 8.05
RNAseq Analysis in glioblastoma cells treated with Mepazine 8.04
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 8.01
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 8.0
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 7.91
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 7.85
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 7.83
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 7.82
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 7.81
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 7.74
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 7.72
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 7.72
RNA-seq of tumor cells following angiopellosis extravasation 7.72
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 7.69
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 7.68
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 7.67
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 7.64
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 7.52
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 7.52
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 7.52
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 7.41
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 7.4
A transcriptome-wide divergence in protein translation scales with LIN28B expression 7.4
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 7.38
Searching for target genes of miR-508/509/506/514 in HCT116 cells 7.37
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 7.36
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 7.34
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 7.33
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 7.31
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 7.31
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 7.28
Tumor exosome integrins determine organotropic metastasis 7.22
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 7.21
Genome wide miR-191 target profile determined by RIP and gene expression profiling 7.15
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 7.15
Biological effect of chronic mistranslation in mammalian cells 7.09
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 7.09
A transcriptome dataset revealing the molecular features of breast cancer stem cells 7.09
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 7.09
Tracing Enhancer Networks using Epigenetic Traits (TENET) 7.08
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 7.06
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 7.01
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 7.01
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 6.98
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 6.98
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 6.97
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 6.95
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 6.93
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 6.93
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 6.93
The conserved transcriptional landscapes in human spermatogenesis 6.92
RNAseq Study in CC-671 Treated Cal-51 Cells 6.9
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 6.88
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 6.87
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 6.84
LncRNA-GAS5 negative regulation of YAP-target genes expression 6.83
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 6.8
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 6.78
Gene expressions of H9s in different culture systems 6.76
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 6.75
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 6.73
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 6.73
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 6.73
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 6.68
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 6.68
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 6.67
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 6.64
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 6.62
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 6.62
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 6.62
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 6.58
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 6.56
4sU-seq of HFF exposed to salt and heat stress 6.54
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 6.51
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 6.51
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 6.51
UBC9 knockdown in bladder cancer T24 cell lines 6.5
In vitro modeling of human germ cell development using pluripotent stem cells 6.5
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 6.47
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 6.46
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 6.45
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 6.38
Lysine benzoylation is a novel histone mark [RNA-seq] 6.38
Lysine benzoylation is a novel histone mark 6.38
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 6.36
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 6.33
RNA-seq of MDA-MB-231 cells with TET1 knockout 6.31
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 6.3
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 6.23
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 6.22
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 6.17
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 6.13
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 6.06
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 6.04
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 6.0
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 5.99
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 5.99
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 5.99
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 5.95
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 5.95
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 5.88
RNA-seq of MCF10A cells and CAF 5.88
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 5.86
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 5.86
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 5.84
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 5.79
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 5.75
Primary human trophoblast from term placenta 5.71
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 5.68
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 5.66
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 5.64
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 5.6
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 5.57
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 5.51
ETV7 and interferon response 5.51
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 5.5
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 5.5
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 5.45
Human HAP1 cells before and after nutrient deprivation 5.45
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 5.42
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 5.4
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 5.37
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 5.36
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 5.34
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 5.33
RNA-Seq in neutrophils from Antiphospholipid Syndrome 5.32
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 5.31
Effect of CHKA knockdown on C4-2 cell transcriptome 5.31
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 5.28
Gene expression profile in breast cancer cells 5.28
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 5.24
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 5.21
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 5.2
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.19
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.19
Ebola virus (EBOV) infection of ARPE-19 cells 5.19
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 5.16
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 5.13
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 5.13
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 5.13
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 5.09
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 5.04
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 5.01
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 4.87
Hepatitis C virus functionally sequesters miR-122 4.87
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 4.87
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 4.86
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 4.86
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 4.85
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 4.85
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 4.82
SRSF1 role in cellular gene expression and splicing 4.8
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 4.78
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 4.77
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 4.74
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 4.74
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 4.69
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 4.66
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 4.66
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 4.66
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 4.64
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 4.61
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 4.61
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 4.6
RNA-seq of naive and primed ES cells 4.59
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 4.53
Primate-specific gene TMEM14B promotes cortical expansion and folding 4.49
RNA-seq of cells with TET1 knockout 4.49
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 4.49
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 4.45
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 4.43
Loss of CREBBP results in gene expression repression in lymphoma cells 4.43
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 4.43
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 4.42
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 4.42
K562 polyA RNA-Seq 4.29
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 4.29
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 4.28
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 4.26
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 4.25
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 4.23
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 4.2
Active translatome profiling with RiboLace in MCF7 cells 4.19
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 4.16
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 4.09
Human embryonic stem cells in E8 and AKIT culture medium 4.09
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 4.08
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 4.08
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 4.04
Generation of KRAS signatures using immortalized isogenic lung cells. 4.02
Transcriptional profile in human S. haematobium infection 4.0
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 3.98
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 3.95
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 3.94
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 3.93
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 3.89
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 3.87
Gene expression in GBM with Cav3.2 inhibition 3.83
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.83
MRTF activates TEAD-YAP target gene expression 3.73
Molecular Criteria for Defining the Naive Human Pluripotent State 3.72
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.68
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.68
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 3.66
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 3.66
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 3.65
RNA Sequencing of Human iPS derived Cardiomyocytes 3.64
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 3.63
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 3.62
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 3.6
mRNA expression in human DAOY cells 3.58
Long non-coding RNAs are central regulators of the IL-1b-induced inflammatory response in human lung fibroblasts 3.56
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.56
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.56
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 3.55
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 3.55
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 3.55
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 3.52
Transcriptomic analysis of LSD1 3.49
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.48
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.43
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 3.41
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 3.36
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.33
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.28
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 3.28
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 3.24
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 3.23
Universal alternative splicing of noncoding exons 3.17
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 3.17
Effect of drugs on transcriptomic profiles 3.17
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 3.16
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 3.14
RNA-seq of IL-4 stimulated human keratinocytes 3.14
UV_24h_GRO-Seq 3.12
O-glcnAc reprograms cellular energetics 3.1
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 3.07
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 3.06
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 3.06
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.94
Copper Regulation of HIF-1 Transcription Activity 2.94
RNA-seq of SCLC PDX models treated with EP 2.94
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.85
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 2.83
Analyses of T-ALL (COG study) 2.83
RNA sequencing of T-ALL (COG study) 2.83
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 2.81
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 2.79
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 2.78
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 2.76
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 2.72
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 2.72
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 2.61
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 2.59
Mapping interactions for the TNIP2 hub protein 2.57
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 2.53
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 2.52
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 2.49
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 2.46
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 2.39
MAIT cell RNA sequencing 2.33
METTL3 and WTAP 2.31
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 2.29
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.27
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 2.24
Leucegene: ALL sequencing 2.22
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 2.22
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 2.2
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 2.16
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 2.1
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 2.09
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 2.07
KLF6-dependent transcription in renal cancer cells 2.05
High-resolution comparative analysis of great ape genomes 2.02
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 1.98
Single-cell analysis of human kidney organoids 1.93
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.9
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.84
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.83
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.83
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 1.78
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 1.73
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 1.61
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.54
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 1.54
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.38
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.38
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.37
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.32
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.31
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 1.28
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 1.26
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.21
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 1.2
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 1.2
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 1.19
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.19
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 1.18
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.18
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.18
Gene expression analysis in response to hypoxic pathway inhibition 1.16
Specific molecular signatures underlie response to decitabine in CMML 1.12
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 1.12
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 1.11
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 1.09
The DPYSL2 gene connects mTOR and schizophrenia 1.09
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 1.07
Function and hormonal regulation of GATA3 in human first trimester placentation 1.01
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.95
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 0.93
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.93
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.93
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.93
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.9
Ribosomal protein RPL26 is the principal target of UFMylation 0.9
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 0.83
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.83
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 0.77
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.71
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 0.68
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.66
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.65
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.6
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.59
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.57
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.52
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.5
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.5
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.47
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 0.46
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.45
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.44
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.44
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.42
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.4
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.39
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.39
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 0.36
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 0.36
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.36
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.35
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.3
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.3
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.29
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.27
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.24
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 0.23
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.22
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.17
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.17
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 0.17
SNHG5 siRNA knock down in HCT116 cells 0.15
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.15
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.13
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.13
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.13
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 0.13
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 0.13
Metastasis in triple-negative breast cancer 0.12
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.12
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.11
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 0.11
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 0.11
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.1
EGR1-controlled transcriptome of T HESCs 0.07
Transcriptome analysis of human lung epithelial cells 0.07
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.06
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.06
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.05
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.04
Comparative Analysis of Cas9 Activators Across Multiple Species 0.02
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation